Qingxin Xia

机构：Zhengzhou University, Henan Cancer Hospital, The University of Osaka · ORCID：0000-0003-0216-9179

发表论文 144 篇 · 总被引 1177 次 · h-index 20

代表论文

• The expression and clinical significance of serum exosomal-long non-coding RNA DLEU1 in patients with cervical cancer (2024 · Annals of Medicine · 被引 11)
• TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B–cell lymphoma (2025 · Frontiers in Oncology · 被引 9)
• Loss of Skeletal Muscle Mass Is Associated With Reduced Cytotoxic T Cell Abundance and Poor Survival in Advanced Lung Cancer (2025 · Journal of Cachexia Sarcopenia and Muscle · 被引 6)
• Integrated microbiome-metabolome profiling unveils a predictive signature for early recurrence in hepatocellular carcinoma (2025 · Frontiers in Microbiology · 被引 5)
• Neoadjuvant camrelizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma: a single-arm, phase 2 trial (2025 · Gastric Cancer · 被引 5)
• Application of Neoadjuvant Docetaxel plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II Trial (2025 · Clinical Cancer Research · 被引 4)